Recall: D-0150-2024

Class II - Potentially Harmful

Class IIClassification

2023-12-04Initiated

TerminatedStatus

SUN PHARMACEUTICAL INDUSTRIES Firm

Product

Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India. NDC 62756-589-88

Reason

Failed Impurities/Degradation Specifications

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.